GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (WBO:ZOTS) » Definitions » Deferred Tax

Zoetis (WBO:ZOTS) Deferred Tax : €-56 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Zoetis Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Zoetis's change in deferred tax for the three months ended in Dec. 2023 was €-19 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was €-56 Mil.

Zoetis Deferred Tax Historical Data

The historical data trend for Zoetis's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Deferred Tax Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only -71.10 -50.96 -70.80 -269.98 -55.94

Zoetis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -166.14 7.47 -31.38 -13.12 -19.26

Zoetis Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-56 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Deferred Tax Related Terms

Thank you for viewing the detailed overview of Zoetis's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoetis (WBO:ZOTS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (WBO:ZOTS) » Definitions » Deferred Tax
Comparable Companies
VTRS NBIX CTLT ITCI ELAN LNTH ALKS PRGO PBH ALVO XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB
Traded in Other Exchanges
ZTS:USA ZTS:Mexico 1ZTS:Italy ZOE:Germany Z1TS34:Brazil
Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Website
https://www.zoetis.com
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (WBO:ZOTS) Headlines

No Headlines